Peer-reviewed veterinary case report
Protein-losing enteropathy in Pugs - treatment and outcomes
By Kathrani, A. et al.·Published in Journal of Small Animal Practice·2026·Department of Clinical Science and Services Royal Veterinary College Hatfield UK, United Kingdom·View original on Crossref →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Clinical management and outcomes for 51 Pugs reportedly diagnosed with protein‐losing enteropathy using VetCompass primary care veterinary data
Plain-English summary
A group of 51 Pugs diagnosed with protein-losing enteropathy (a condition that causes loss of protein through the intestines) were treated at veterinary clinics in the UK. Many of these dogs were given prednisolone, a steroid that helps reduce inflammation, and clopidogrel, a medication that can improve blood flow. The results showed that dogs treated with these medications had a better chance of surviving in the first three months after diagnosis. Unfortunately, about 43% of the Pugs died due to the condition, often within three months of being diagnosed.
People also search for: Pug protein-losing enteropathy treatment · prednisolone for dogs · Pug intestinal disease symptoms
Abstract
Objectives To report the clinicopathological findings, treatment and outcomes of Pugs diagnosed with protein‐losing enteropathy using VetCompass primary care clinical data in the UK and to determine if referral or any specific treatments for protein‐losing enteropathy were associated with outcome. Materials and Methods Retrospective VetCompass study of primary care practice records for Pugs with a recorded diagnosis of protein‐losing enteropathy. Of the 51 Pugs diagnosed with protein‐losing enteropathy between 2017 and 2024 in the UK, clinicopathological results, referral status, treatment and outcome on protein‐losing enteropathy were extracted. Results Twenty‐one of 51 Pugs (41.2%) were referred for protein‐losing enteropathy care. Thirty‐four (66.7%) were treated with prednisolone, 2 (3.9%) with cyclosporin, 6 (11.8%) with chlorambucil and 14 (27.5%) with clopidogrel. Twenty‐two of 51 Pugs (43.1%) died presumed due to their protein‐losing enteropathy, with 54.5% of these deaths occurring within 3 months of diagnosis. More Pugs alive at 3 months compared to those that died within 3 months were treated with prednisolone (28/34 alive vs. 5/12 dead; P =.032) and clopidogrel (14/34 alive vs. 0/12 dead; P =.009). There was no difference between referred and non‐referred Pugs in their probability of being alive versus those that died due to their protein‐losing enteropathy at 3 months (17/34 alive vs. 3/12 dead; P =.183), 1 year (11/24 alive vs. 6/17 dead; P =.539) and 2 years (7/13 alive vs. 8/19 dead; P =.720). Clinical Significance Studies that account for severity of disease are needed to determine if Pugs with protein‐losing enteropathy managed completely in primary care have similar outcomes versus referral. Prednisolone and clopidogrel may increase short‐term survival; however, prospective studies are needed to confirm this.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on Crossref: https://doi.org/10.1111/jsap.70094